chevron_leftBack
As of 13 June 2026, Nuo Therapeutics, Inc. has a market cap of $55.36M USD, ranking #29852 globally and #4394 in the United States.
It ranks #2696 in the Healthcare sector, and #558 in the Medical Devices industry.
Key Stats
Market Cap
$55.36MUSD
Enterprise Value
$54.91MUSD
Revenue (TTM)
$3.31MUSD
EBITDA (TTM)
-$2.43MUSD
Net Income (TTM)
-$2.51MUSD
EBITDA Margin
-73%
Profit Margin
-76%
PS Ratio
16.7
PB Ratio
-57.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
David Jorden
open_in_new
Employees
10
Founded
1998
Website
nuot.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -12% | -17% | -21% | -28% | -51% | -24% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
AURX
Nuo Therapeutics Inc Ordinary Shares
ISIN: US67059V2097
Shares Out.:
Shares Outstanding:
48.409M1
Shares Float:
20.212M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.14 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
313K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
290K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
287K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
229K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
218K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
153K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
184K%
|
22.2
|
|
EPA: EL
|
$97.46B
176K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
111K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
82K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
66K%
28.99B CHF
|
37.9
|
|
|
$30.06B
54K%
203.66B CNY
|
26.0
|
chevron_leftBack